Result of the AMSTAR-2 assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Characteristics of included reviews. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Result of the PRISMA assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Result of the ROBIS assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Evolution of arterial redox potential during CPB. by Vincent Pey (21433304)

Supplementary Material for: Significant Dry Weight Reduction After Transition from Peritoneal Dialysis to Hemodialysis by Lin Y.-T. (17065287)

“…After transitioning to HD, body weight decreased significantly, with a reduction of -2.8 kg at one month, -5.3 kg at three months, and -7.5 kg one year post-transition. …”

A prepubertal CD decreases fat mass accumulation and prevents lean mass loss in adulthood despite a chronic HFD in Sprague-Dawley male rats. by Ana Aguilar-Lozano (20614619)

Pathological changes in lung tissue of mice exposed to continuous inhalation of CS. by Yue He (385239)

Pathways analysis of ERCC1 based on CWP metabolome and proteome. by Hao Deng (409186)

Procedure for attaching the eye drop bottle and instilling eye drops. by Yuka Kasai (21354922)

Subjects:

Demographics of the enrolled patients. by Yuka Kasai (21354922)

Subjects:

The video demonstrates how to use the eye drop aid. by Yuka Kasai (21354922)

Subjects:

Overhead view of the eye drop aid. by Yuka Kasai (21354922)

Subjects:

Comparison of eye drop instillation success rates across different age groups. by Yuka Kasai (21354922)

Subjects:

ONSD modifications induced by arterial paCO₂ changes. by Marco Carbonara (11483575)

Subjects:

Enrollment flow-chart. by Marco Carbonara (11483575)

Subjects:

Table 1 - by Marco Carbonara (11483575)

Subjects:

Optic Nerve Sheath Diameter (ONSD) in mm, measured by ultrasound. by Marco Carbonara (11483575)

Subjects:

ONSD at T14 and six months after ICU discharge. by Marco Carbonara (11483575)

Subjects:

Bland-Altman plot indicating the agreement between the optic nerve sheath diameter measured with CT scan and US. by Marco Carbonara (11483575)

Subjects: